MedTrace Logo

18F-FAPI PET/CT in Patients With Various Types of Cancer

NCT05810324 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2023-04-12

No results posted yet for this study

Summary

To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

Conditions

Interventions

DRUG

18F-FAPI

Each patient receive a single intravenous injection of 18F-FAPI, and undergo PET/CT scan within specified time.

Sponsors & Collaborators

  • Jilin University

    lead OTHER

Principal Investigators

  • Bin Ji · China-Japan Union Hospital, Jilin University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-07-01
Completion
2025-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810324 on ClinicalTrials.gov